Thiogenesis Therapeutics Corp.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.1040 USD
−2.19 M USD
0.00 USD
43.08 M
About Thiogenesis Therapeutics Corp
Sector
Industry
CEO
Patrice P. Rioux
Website
Headquarters
Toronto
Founded
2018
ISIN
CA88410L1022
FIGI
BBG01BQ5D3H5
Thiogenesis Therapeutics Corp. engages in developing novel drug formulations that act as precursors for rare diseases. The company was founded in 2018 and is headquartered in Toronto, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
The current price of TTIPF is 0.5834 USD — it has decreased by −0.27% in the past 24 hours. Watch Thiogenesis Therapeutics Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Thiogenesis Therapeutics Corp. stocks are traded under the ticker TTIPF.
TTIPF reached its all-time high on Jun 23, 2025 with the price of 2.5800 USD, and its all-time low was 0.0016 USD and was reached on Jun 25, 2025. View more price dynamics on TTIPF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TTIPF stock is 0.31% volatile and has beta coefficient of 0.61. Track Thiogenesis Therapeutics Corp. stock price on the chart and check out the list of the most volatile stocks — is Thiogenesis Therapeutics Corp. there?
Today Thiogenesis Therapeutics Corp. has the market capitalization of 22.08 M, it has increased by 0.04% over the last week.
Yes, you can track Thiogenesis Therapeutics Corp. financials in yearly and quarterly reports right on TradingView.
Thiogenesis Therapeutics Corp. is going to release the next earnings report on May 13, 2026. Keep track of upcoming events with our Earnings Calendar.
TTIPF net income for the last quarter is −1.71 M USD, while the quarter before that showed −1.40 M USD of net income which accounts for −22.69% change. Track more Thiogenesis Therapeutics Corp. financial stats to get the full picture.
No, TTIPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TTIPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Thiogenesis Therapeutics Corp. stock right from TradingView charts — choose your broker and connect to your account.